Supplementary Figure. Trends in the Estimated Proportions and 95% CIs of SARS-CoV-2 Reverse Transcription–Polymerase Chain Reaction Results With S-Gene Target Presence and SARS-CoV-2 Variant Proportions or Nowcast Projections From Genomic Surveillance Classified As Exhibiting S-Gene Target Presence, Nationally and by Health and Human Services Regions 1–10 — United States, October 30, 2022–January 14, 2023

Details

• Alternative Title:
  Spike Gene Target Amplification in a Diagnostic Assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 Variants — United States, November 2021–January 2023: Supplementary Figure. Trends in the Estimated Proportions and 95% CIs of SARS-CoV-2 Reverse Transcription–Polymerase Chain Reaction Results With S-Gene Target Presence and SARS-CoV-2 Variant Proportions or Nowcast Projections From Genomic Surveillance Classified As Exhibiting S-Gene Target Presence, Nationally and by Health and Human Services Regions 1–10 — United States, October 30, 2022–January 14, 2023
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Source:
  MMWR: Morbidity and Mortality Weekly Report 2023; v. 72, no. 5
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pages in Document:
  1 pdf page
• Volume:
  72
• Issue:
  5
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:9b7fdee602908557bb6a79cd3e11920ee1ba94bdd8b840fbdf00ad2f3d1e72a633198d292da021771d8ca1369b6308fb8de5a960cd5d05af2f34f10966d69c7b
• Download URL:
  https://stacks.cdc.gov/view/cdc/123810/cdc_123810_DS1.pdf
• File Type:
  [PDF - 277.94 KB ]